{
  "Q0": "Whole Exome Sequencing (WES)",
  "Q1": "Not specified",
  "Q2": "No",
  "Q3": "No",
  "Q4": "Yes",
  "Q4_followup": {
    "patient_clinical_presentation_matches": "No",
    "guidelines_apply": "None of the above"
  },
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8_followup": {
    "alternative_test": "Multi-gene targeted panel testing for neuromuscular disorders"
  },
  "Q9": "Not specified",
  "Q10": "No",
  "Q10_followup": {
    "purpose": "Diagnostic"
  },
  "Q11": "Not specified",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "No",
  "Q17": "The policy requires that the test be ordered by or in consultation with a board-certified medical geneticist, developmental pediatrician, or neurologist. Additionally, the clinical presentation must support the use of WES over more targeted genetic analysis. Ensure all medical records and documentation are submitted to demonstrate medical necessity as per the policy.",
  "match": false
}